Utah Medical Products UTMD Deferred Tax Liabilities Depreciation And Amortization
Deferred Tax Liabilities Depreciation And Amortization at other companies
Other financials
Where this comes from
Reported directly by Utah Medical Products in its filing.
Tagged under the XBRL concept fil:DeferredTaxLiabilitiesDepreciationAndAmortization.
The official record: Utah Medical Products’s 10-K, filed March 27, 2026, on SEC EDGAR. View the filing →
Ask your AI about Utah Medical Products's deferred tax liabilities depreciation and amortization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Utah Medical Products's deferred tax liabilities depreciation and amortization?
- Utah Medical Products (UTMD) reported deferred tax liabilities depreciation and amortization of $861K in Q4 2025.
- How has Utah Medical Products's deferred tax liabilities depreciation and amortization changed year-over-year?
- Utah Medical Products's deferred tax liabilities depreciation and amortization decreased by 40.7% year-over-year, from $1.45M to $861K.
- What is the long-term trend for Utah Medical Products's deferred tax liabilities depreciation and amortization?
- Over 5 years (2020 to 2025), Utah Medical Products's deferred tax liabilities depreciation and amortization has grown at a -22.3% compound annual growth rate (CAGR), from $3.03M to $861K.
- What does deferred tax liabilities depreciation and amortization mean?
- This represents the tax liability arising from temporary differences between the depreciation and amortization methods used for financial reporting versus tax reporting purposes. It indicates future tax obligations that will be settled as the underlying assets are fully depreciated or amortized.